Related Experiment Videos
Role of D-dimer in predicting mortality in patients with community-acquired pneumonia
Desa Nastasijević Borovac1, Tatjana Radjenović Petković, Tatjana Pejčić
1Clinic for Lung Diseases, Clinical Center Niš, Knez Selo¹, School of Medicine, University of Niš, Niš²; Serbia.
Aim:
To determine whether D-dimer in patients with communityacquired pneumonia (CAP) can predict mortality risk better than standard biomarkers.
Methods:
White blood cell (WBC), C-reactive protein (CRP) and D-dimer in 129 patients with CAP were analyzed. The recommended Pneumonia Severity Index (PSI) score was used to classify CAP patients into five groups according to the severity of disease (Group PSI I-V), and for predicting mortality. Additionally, the patients were divided in surviving and non-surviving group.
Results:
White blood cell and CRP were not in correlation with the severity of CAP and the risk of mortality. The correlation between plasma D-dimer and severity of CAP was found (r=0.4993; p less than 0.001). The level of D-dimer was significantly higher in nonsurviving (2498.38 ± 1248.83 ng/mL) than in surviving patients (966.44 ± 968.73 ng/mL) (p less than 0.001). In predicting mortality risk, D-dimer showed sensitivity of 0.84 (cut of >1538 mg/mL), specificity 0.86 and AUC 0.859 (95%CI; 0.787-0.914). Pneumonia Severity Index in predicting of mortality risk for cut of > PSI III showed sensitivity of 0.92, specificity 0.62 and AUC 0.868 (95%CI; 0.797-0.921). There was no statistical difference between AUC of PSI and D-dimer (delta AUC= 0.00895) (p=0.9005).
Conclusion:
Coagulation abnormalities were presented in older patients with severe infections and comorbidity. Plasma D-dimer correlated better than standard inflammatory markers with severity of disease and risk of mortality in patients with CAP. In predicting mortality risk, D-dimer did not show difference among the PSI score.
Insights
D-dimer levels in community-acquired pneumonia (CAP) patients correlate with disease severity and mortality risk. While D-dimer showed strong predictive value, it was comparable to the Pneumonia Severity Index (PSI) for mortality prediction.
Area of Science:
- Medical research
- Clinical diagnostics
- Pulmonology
Background:
- Community-acquired pneumonia (CAP) poses a significant health risk, necessitating accurate prognostic markers.
- Standard biomarkers like white blood cell (WBC) count and C-reactive protein (CRP) have limitations in predicting CAP severity and mortality.
- The role of coagulation markers, specifically D-dimer, in assessing CAP prognosis requires further investigation.
Purpose of the Study:
- To evaluate the predictive capability of D-dimer for mortality risk in patients with CAP.
- To compare the efficacy of D-dimer against standard biomarkers (WBC, CRP) and the Pneumonia Severity Index (PSI) in predicting CAP mortality.
- To investigate the correlation between D-dimer levels and CAP severity.
Main Methods:
- Analysis of WBC, CRP, and D-dimer levels in 129 CAP patients.
- Classification of patients into severity groups (PSI I-V) and survival/non-survival groups.
- Statistical analysis to determine correlations and predictive values (sensitivity, specificity, AUC) for D-dimer and PSI in mortality prediction.
Main Results:
- WBC and CRP levels did not correlate with CAP severity or mortality risk.
- Plasma D-dimer showed a significant positive correlation with CAP severity (r=0.4993, p<0.001).
- Non-surviving patients exhibited significantly higher D-dimer levels compared to survivors (p<0.001). D-dimer demonstrated high sensitivity (0.84) and specificity (0.86) for mortality prediction (AUC=0.859).
- The Pneumonia Severity Index (PSI) also showed strong mortality prediction (AUC=0.868), with no statistically significant difference compared to D-dimer (p=0.9005).
Conclusions:
- Coagulation abnormalities, indicated by elevated D-dimer, are associated with severe infections, particularly in older patients with comorbidities.
- Plasma D-dimer is a more effective predictor of CAP severity and mortality risk than standard inflammatory markers.
- D-dimer offers comparable mortality prediction to the PSI score in CAP patients, highlighting its potential clinical utility.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pneumonia III: Complications and Assessment
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism I: Introduction
Venous Thrombosis III: Interprofessional Care